About ThinkCyte
ThinkCyte is a company based in Bunkyo (Japan) founded in 2016 by Ryoichi Horisaki, Sadao Ota, Issei Sato, and Waichiro Katsuda. ThinkCyte has raised $83.18 million across 7 funding rounds from investors including SBI Group, Toyoda Gosei and Sparx Group. ThinkCyte operates in a competitive market with competitors including NanoCellect Biomedical, Singulex, Cell Microsystems, Silicon Biosystems and Immunicon, among others.
- Headquarter Bunkyo, Japan
- Founders Ryoichi Horisaki, Sadao Ota, Issei Sato, Waichiro Katsuda
- SectorsHealthcareTechnology
- Website thinkcyte.com
- Social LinkedIn X
- Total Equity Funding$83.18M (USD)
in 7 rounds
- Latest Funding Round$14.88M (USD), Series C
Aug 2024
- InvestorsSBI Group
& 18 more
Funding Insights of ThinkCyte
ThinkCyte has successfully raised a total of $83.18M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $14.88 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $83.18M
- Total Rounds 7
- Last Round Series C — $14.88M
- First Round $3.2M
(Jun 2018)
- Investors Count 19
All 7 funding rounds of ThinkCyte with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2024 | $14.88M | Series C | – | Decarbonization Support, Kirin Holdings | – |
| Nov 2023 | – | Grant | – | – | – |
| Nov 2023 | $24M | Series C | – | Nomura Sparks Investment | |
| May 2021 | $26M | Series B | – | SPARX Group, Sysmex | – |
| May 2020 | $15M | Series A | – | SPARX Group | |
| Jul 2018 | $100,000 | Seed | – | Berkeley SkyDeck | – |
| Jun 2018 | $3.2M | Seed | – | – |
19 investors in total: 19 institutional.
Investors in ThinkCyte
ThinkCyte has secured backing from 19 investors, including institutional and venture fund investors. Prominent investors backing the company include SBI Group, Toyoda Gosei and Sparx Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | smbc-vc.co.jp | - | |
- | – | smtic.jp | - | |
Venture capital firm investing in early-stage startups | – | techv.co.jp/en/ | Minato, Japan | |
- | – | realtech.fund | - | |
Startups are accelerated and incubated across diverse industries. | 2012 | skydeck.berkeley.edu | Berkeley, United States | |
Provides comprehensive solar services for commercial and residential clients. | 2010 | teitannso.jp | Nagoya, Japan | |
Financial services for investment industries are provided by Kirin Holdings. | 2010 | kirinholdings.com | Nakano, Japan | |
- | – | jfc.go.jp | - | |
Automotive components are manufactured and supplied to the aftermarket. | 1949 | toyoda-gosei.com | Kiyosu, Japan | |
Provides investment management services specializing in portfolio construction and risk assessment. | 2021 | nomura-sparx-investment.com | Chiyoda City, Japan |
Investor details for ThinkCyte
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ThinkCyte
22 people are tracked at ThinkCyte (10 in leadership, 1 in board & advisors, 11 in team).
| Name | Role | Group |
|---|---|---|
Ryoichi Horisaki | Co-Founder | Leadership |
Sadao Ota | Co-Founder & CTO | Leadership |
Issei Sato | Co-Founder | Leadership |
Waichiro Katsuda | Co-Founder & CEO | Leadership |
Keiji Nakagawa | Chief Product Officer | Leadership |
Yoko Kawamura | Head Of Applied Microfluidics | Leadership |
Eiji Nara | VP, IP & Legal Affairs | Leadership |
Ryo Otsuki | Chief Financial Officer | Leadership |
Hikaru Nagahori | Chief Operating Officer | Leadership |
Tsuyoshi Harada | Head Of Corporate Development | Leadership |
David Basiji | Director | Board & advisors |
Kazuki Teranishi | Product Manager | Team |
Asako T. | HR Manager | Team |
Joel Koerwer | Optical Research Engineer | Team |
Dr.juliet Packiasamy | Senior Scientist | Team |
Yuuki Onda | Research Associate II | Team |
Paul Fallon | Field Application Scientist | Team |
Ryan Nino | Supply Chain Manager | Team |
Greg Schneider | Application Manager | Team |
Eric Zheng | Firmware And Software Engineering Manager | Team |
2 more people are available in the full profile.
Complete people profiles for ThinkCyte
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ThinkCyte
3 dated milestones of ThinkCyte across 8 years, from founding to its latest funding, stage changes and deals.
- Founded ThinkCyte is founded.
- Funding First funding round of $3.2M.
- Funding Latest funding round, Series C, of $14.9M.
Competitors of ThinkCyte
ThinkCyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NanoCellect Biomedical, Singulex, Cell Microsystems, Silicon Biosystems and Immunicon, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nanocellect.com | 2009 | San Diego, United States | $78.15M | 84 | Develops flow cytometry and cell sorting technology | |
| singulex.com | 1997 | Alameda, United States | $140.94M | 236 | Single-molecule counting technology is developed for cardiovascular biomarker detection. | |
| cellmicrosystems.com | 2009 | Durham, United States | $19.1M | – | Developer of a technology to isolate and recover single cells for molecular analysis | |
| siliconbiosystems.com | 1999 | Bologna, Italy | $25.53M | – | Lab-on-a-chip technologies for miniaturized cell-biology testing are developed. | |
| immunicon.com | 1983 | Bryn Athyn, United States | $75.35M | – | Cell and molecular-based diagnostics for cancer management are developed. | |
| fdsonics.com | 2010 | Wilbraham, United States | $34.82M | 7 | Developer of acoustic particle trapping systems for applications in research and public health | |
| cytomos.com | 2012 | Edinburgh, United Kingdom | $13.55M | 15 | Point-of-care cell sorter is developed for research and diagnostics. | |
| cytena.com | 2014 | – | $4.59M | 71 | Single cells are isolated using the cy-Clone device technology. | |
| nodexus.com | 2014 | Berkeley, United States | $31.2M | 27 | Microfluidic systems are developed for detecting metastatic cancer. |
Detailed competitors of ThinkCyte
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ThinkCyte
The website of ThinkCyte (thinkcyte.com) receives about 6.5K visits a month.
- Monthly visits6.5K
▲ 34.6% vs previous month
Websites whose visitors overlap most with ThinkCyte. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| kepple.co.jp | 100% | 25.8K | #1,094,889 | View details | |
venture.jp | venture.jp | 60% | – | #1,220,168 | – |
projectdesign.jp | projectdesign.jp | 40% | – | #624,936 | – |
Latest news on Thinkcyte
Complete news archive for ThinkCyte
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to ThinkCyte
10 companies that operate in the same segment as ThinkCyte (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ThinkCyte
ThinkCyte was founded in 2016 and raised its 1st funding round 2 years after it was founded.
ThinkCyte is headquartered in Bunkyo, Japan. It is registered at Bunkyo, Tokyo, Japan.
Waichiro Katsuda is the current CEO of ThinkCyte. They have also founded this company.
ThinkCyte is a funded company, having raised a total of $83.18M across 7 funding rounds to date. The company's 1st funding round was a Seed of $3.2M, raised on Jun 2018.
ThinkCyte was established in 2016 in Bunkyo, Japan, within the biotechnology sector. Advanced cell analysis and sorting solutions are provided through technologies like VisionSort. Fluorescence flow cytometry is combined with high-dimensional morphological profiling and artificial intelligence. Label-free cell sorting and unbiased single-cell profiling are facilitated for research applications. Operations focus on innovative tools for cellular examination across global scientific communities.
ThinkCyte's top competitors include NanoCellect Biomedical, Silicon Biosystems and Singulex.
ThinkCyte has 19 investors. Key investors include SBI Group, Toyoda Gosei, Sparx Group, Tokyo Century, and Sysmex.